Article type: Letter to Editor
Article
title: Hyperhidrosis,
oromandibular dystonia, and botulinum toxin type a (botox)
Journal: Medical
Journal of Dr. D.Y. Patil Vidyapeeth
Year: 2022
Authors: Jamir
Pitton Rissardo, Ana Letícia Fornari Caprara
E-mail:
jamirrissardo@gmail.com
ABSTRACT
Hyperhidrosis is characterized by excessive sweating
due to the over-stimulation of cholinergic receptors on eccrine glands, in
which the acetylcholine negative feedback loop is probably impaired. The
prevalence in the United States is about 3%, and can significantly impair the
quality of life of the affected individuals. The management of this disorder is
based initially on topical aluminum chloride and oral anticholinergic
medications. Sympathectomy and botox are reserved for severe and resistant
cases. Herein, we would like to address some important topics from recently
published articles about hyperhidrosis to achieve a better comprehension of the
management of this disorder.
Keywords: Hyperhidrosis, oromandibular
dystonia, botulinum toxin
Full text available at:
https://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2022;volume=15;issue=5;spage=815;epage=816;aulast=Rissardo
DOI
10.4103/mjdrdypu.mjdrdypu_242_21
Citation
Rissardo JP, Fornari Caprara AL. Hyperhidrosis, oromandibular dystonia, and botulinum toxin type a (Botox). Med J DY Patil Vidyapeeth 2022;15:815-6
